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The aim of the study was to assess the relationship between the dietary polyphenol intake (DPI) and the dietary total antioxidant
capacity (DTAC) and the prevalence of cardiovascular disease (CVD) in postmenopausal women. Participants were 916
postmenopausal women diagnosed with CVD and 1683 postmenopausal women without history of CVD, who took part in the
population-based studies carried out in Poland: WOBASZ (2003–2005) and WOBASZ II (2013-2014). Nutritional data were
collected using a single 24-hour dietary recall. DPI and DTAC in the CVD women were significantly lower and accounted for
1766.39mg/d and 10.84mmol/d, respectively, versus 1920.57mg/d and 11.85mmol/d in the women without CVD, but these
differences disappeared after the standardization for energy input. Also, in the multiple-adjustment model, higher DPI, but not
DTAC, was associated with the reduced odds ratio for the prevalence of CVD. Beverages, mainly coffee and tea, contributed in
more than 40% to DPI and in more than a half to DTAC. In this study, higher dietary polyphenol intake, but not the dietary
total antioxidant capacity, was inversely associated with CVD in postmenopausal women, which points to the health benefits of
increased polyphenol intake from food sources for these women.
1. Introduction
Cardiovascular disease (CVD) is the leading cause of
mortality in postmenopausal women [1]. Unfavorable
behavioral factors during the life as tobacco use, physical
inactivity, unhealthy diet, and harmful use of alcohol are
fundamental for CVD risk [2]. Deleterious lifestyle
patterns translate to the occurrence of intermediate risk
factors as raised blood glucose and lipid levels, increased
blood pressure, and overweight/obesity [3]. CVD incidence
increases with age, and particularly in women, which
raises after menopause. Termination of the secretory
ovarian function contributes to this morbidity [4].
Because life expectancy has improved and can be up to
one-third after menopause and due to increased morbid-
ity and mortality, postmenopausal women should be
targeted with all sorts of activities that would reduce
the risk of CVD.
At the ground of several chronic diseases that include
CVD, diabetes, neurodegenerative diseases (Parkinson’s dis-
ease and Alzheimer’s disease), and cancer and aging is oxida-
tive stress [5]. An excessive generation of extremely reactive
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oxygen species (ROS) in the body leads to oxidative damage
to cellular structures [6]. Some evidence suggests that
mechanisms of antioxidant protection can deteriorate with
age [7]. Furthermore, heart tissues of elderly people tend to
be more vulnerable to oxidative stress, because of the
disturbed metabolism in the mitochondria, which leads to
oxidative injury [8]. Dietary antioxidants are one of the
several lines of defense against cardiovascular disease, dia-
betes, and cancer. The most important are redox-active
dietary constituents as vitamins C and E, carotenoids,
and polyphenols [9].
Polyphenols, which are secondary plant metabolites, dis-
play potential health effects. The main classes of phenolic
compounds include phenolic acids, flavonoids, stilbenes,
and lignans [10]. Food products are generally sources of all
classes of polyphenols, but they occur in different propor-
tions. The most abundant dietary polyphenols, however, are
phenolic acids and flavonoids [11].
The aim of the study was to assess the relationship
between the dietary polyphenol intake (DPI) and the dietary
total antioxidant capacity (DTAC) and the prevalence of
CVD in postmenopausal women and to establish the main
dietary sources of polyphenols and antioxidants in postmen-
opausal women with and without history of CVD.
2. Material and Methods
2.1. Participants. The study examined general, anthropomet-
ric, biochemical, and dietary data collected from 2599
postmenopausal women, participants of the two largest
population-based cross-sectional studies carried out in
Poland: Polish National Multicenter Health Examination
Surveys—WOBASZ (2003–2005) and WOBASZ II (2013-
2014), which were carried out by the National Institute of
Cardiology, Warsaw, Poland, in collaboration with five Pol-
ish medical universities. The rationale, design, and methods
of the WOBASZ and WOBASZ II studies were described in
previous publications [12–14]. Women were selected for
the current analysis on the basis of the occurrence of natural
menopause and on the basis of completed records. Uniform
criteria of six months from the termination of menstruation
have been adopted in both WOBASZ studies in accordance
with the study manual. The exclusion criteria were preg-
nancy and surgical menopause. Then, a group of 916 women
with medically diagnosed cardiovascular disease (CVD) was
extracted from the general study group of postmenopausal
women. The remaining women without past history of
CVD have served as control. The flow chart of the study par-
ticipants is provided in Figure 1.
2.2. Data Collection. Data on marital status, level of educa-
tion, menopause status, family history of CVD, history of
myocardial infarction or stroke, medications and supple-
ments used, leisure-time physical activity, alcohol intake,
and smoking habit were collected from a self-reported stan-
dardized questionnaire designed for the WOBASZ study.
Cardiovascular disease (CVD) classification was adopted in
accordance with the WHO [15]. Hypertension has been
recognized if systolic BP≥ 140mmHg and/or diastolic
BP≥ 90mmHg and/or when antihypertensive drugs were
WOBASZ WOBASZ II
14,769 participants aged 20−74 y
evaluated during general assessment
(6977 men and 7792 women)
6170 participants aged 20+ y
evaluated during general assessment
(2760 men and 3410 women)
7256 completed dietary assessment
(3418 men and 3838 women)
5690 completed dietary assessment
(2554 men and 3136 women)
1253 women selected
according to menopause criterion
(6 months from the last menstrual period)
1346 women selected according to
menopause criterion (6 months from
the last menstrual period)
diagnosed with CVD
without history of CVD
(i) 916 postmenopausal women
(ii)1683 postmenopausal women
Figure 1: Flow chart of the study participants.
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used. Criteria for diabetes were glucose level≥ 7.0mmol/L
and/or the use of glucose-lowering drugs. Two categories of
the marital status were included: married and singles, while
“singles” were widows, unmarried women, divorced, and
separated. Education level was given in three categories: (1)
under middle—no education, partial or completed education
for primary level, vocational lower secondary education, and
partial secondary education; (2) middle—secondary
Table 1: General description of the studied postmenopausal women with and without CVD.
Trait
Women diagnosed with CVD
N = 916
Women without CVD
N = 1683
Significance
level
Mean± SD or % Mean± SD or % p
Age (years) 65.5± 9.2 60.98± 8.4 <0.0001
Marital status (%)
Married 57.2 63.9 0.001
Single 42.8 36.1
Level of education (%)
Under middle 61.0 55.2 0.009
Middle 31.9 35.4
Academic 7.1 9.5
Age of natural menopause (years), mean, SD, range 49.9± 4.4 50.0± 4.1 0.875
Duration of menopause (years), mean, SD, range 15.6± 9.6 11.0± 8.6 <0.0001
Family history of CVD (%) 39.4 36.1 0.098
Diseases (%)
Hypertension 73.1 57.3 <0.0001
Myocardial infarction 12.6 0 <0.0001
Stroke 7.9 0 <0.0001
Diabetes 19.8 13.4 <0.0001
Medication
Menopause hormone therapy (%) 3.8 4.9 0.178
Hypotensive drugs (%) 61.0 34.9 <0.0001
Cholesterol-lowering therapy (%) 29.3 13.5 <0.0001
Antidiabetic medication or insulin (%) 15.6 8.2 <0.0001
Smoking status (%)
Current smokers 12.5 20.9 <0.0001
Past smokers 18.6 17.7
Never smokers 68.9 61.4
Leisure-time physical activity (%)
Low level 52.1 47.8 0.107
Middle level 16.5 18.4
High level 31.3 33.8
BMI (kg/m2) (%)
Underweight (BMI< 18.5) 0.3 0.7 <0.0001
Normal (BMI 18.5–24.99) 28.2 27.8
Overweight (BMI 25–29.99) 35.2 39.2
Obesity (BMI> 30) 44.3 32.2
Abdominal obesity (%) 71.1 62.5 <0.0001
Supplementation with antioxidant vitamins (A, C, and
E) (%)
9.9 8.9 0.391
Alcohol intake (g pure ethanol/day), mean, SD 0.7± 2.7 1.0± 2.9 <0.0001
Fasting glucose (mmol/l), mean, SD 5.7± 1.9 5.5± 1.6 0.531
Total cholesterol (mmol/l), mean, SD 5.4± 1.2 5.8± 1.3 <0.0001
LDL cholesterol (mmol/l), mean, SD 3.2± 1.1 3.6± 1.1 <0.0001
HDL cholesterol (mmol/l), mean, SD 1.4± 0.4 1.5± 0.4 <0.0001
Triglyceride (mmol/l), mean, SD 1.6± 1.0 1.5± 0.8 0.1006
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education and partial academic education; and (3) academic
education. Smoking status was assessed in three categories:
current smokers, past smokers, and never smokers, depend-
ing on a habit of smoking at least one cigarette a day. Physical
activity at leisure was assessed at a low level—when there was
no such physical activity, for example, jogging, cycling,
swimming, and gardening for at least 30 minutes a day or
only occasional activity (once a week, several times a month,
and several times a year); middle level—physical activity, for
example, jogging, cycling, swimming, and gardening was for
at least 30 minutes a day every second or third day; and high
level—physical activity as given above every day or almost
every day. Body measurements, such as height, body mass,
and waist circumference were taken by the personnel trained
in standard procedures. The body mass index (BMI) was cal-
culated as weight in kilograms divided by the square of height
in meters. Abdominal obesity has been recognized if waist
circumference was >88 cm. Supplementation with at least
one of the antioxidant vitamins (A, C, and E) was collected
from the self-reported WOBASZ questionnaire. Blood pres-
sure (BP) was measured three times on the right arm after
5 minutes of resting in a sitting position in one-minute inter-
vals, and the final BP was calculated as an average of the sec-
ond and third measurements. Biochemical analyses, as
fasting glucose, total cholesterol, LDL cholesterol, HDL cho-
lesterol, and triglycerides, were carried out at the Central
Laboratory of the National Institute of Cardiology, Warsaw.
General description of the study group, stratified by CVD
status, is given in Table 1.
The WOBASZ study protocol was approved by the Bio-
ethics Committee of the National Institute of Cardiology
(WOBASZ, number 708) and (WOBASZ II, number 1344).
2.3. Dietary Assessment. Nutritional data were collected by
qualified interviewers using a single 24-hour dietary recall.
On the basis of the recalls, it was found that 367 dishes, food
items, and beverages consumed by the participants were
sources of polyphenol intakes. These products were grouped
into 5 food categories: beverages (alcoholic and nonalcoho-
lic)—coffee, tea, wine, beer, fruit drinks, and juices; cereals—
bread (wheat, rye, and mixed), groats, and macaroni; fruit
(fresh, frozen, dried, and jam); vegetables (fresh, frozen, pick-
led, and legumes); and other food products—cocoa products
(chocolates—semisweet chocolate, bitter chocolate, and
white chocolate; cocoa), nuts and seeds (almonds, peanut,
coconut, hazelnuts, pistachio, walnuts, poppy seeds, sesame
seeds, sunflower seeds, and pumpkin seeds), cookies and pas-
try, and other sweets (candies, etc.). The meal preparation
techniques were taken into consideration as factors affecting
the polyphenol contents of food items. Individual compo-
nents of complex dishes have been extracted using dish rec-
ipes from the Polish Food Composition Tables [16]. These
recipes give the amounts of food items required for 100 g dish
portion, with consideration of yield factors. A quantitative
composition of plant components of ready-to-eat foods was
taken according to information given on food labels. For fruit
yoghurt, for example, a typical amount of 5% respective
added fruit has been taken for the calculations.
2.4. Estimation of Dietary Antioxidant Activity and
Polyphenol Intake. Antioxidant activity of food products
was mostly taken from our own databases of ferric-
reducing antioxidant potential (FRAP) of food [17, 18],
which represent mean values of antioxidant activity for 69
food products. Some missing values were complemented
with other databases [19]. Dietary antioxidant activity per
day as well as daily intakes of polyphenols was determined
by multiplying the daily consumption of individual food
items by antioxidant activity and polyphenol contents in
these food items. The intake of total polyphenols was esti-
mated using our own total polyphenol databases [17, 18] as
well as the online Phenol-Explorer database [20]. For the cal-
culation of dietary polyphenol intake (DPI) and the dietary
total antioxidant capacity (DTAC) by different databases,
the same food items and the same culinary techniques were
taken into account.
2.5. Statistical Analyses. Descriptive data for the study pop-
ulation characteristics of women diagnosed with CVD and
of women without history of CVD were calculated as
means and SDs for the continuous variables and as per-
centages for the categorical variables. For comparison pur-
poses of dietary intakes, Student’s t-test was used. DTAC
and DPI are given unadjusted and adjusted to 1000 kcal
to correct for total energy intake. Additionally, all post-
menopausal women were grouped into quartiles based on
DTAC and DPI total values. Percentages of women diag-
nosed with CVD were calculated across quartiles of DTAC
and DPI. For nonnormally distributed data, such as con-
tributions of food categories to DTAC and DPI, Kruskal-
Wallis test was used. Odds ratios (ORs) with the corre-
sponding 95% confidence intervals (CIs) for CVD by
DTAC and DPI, unadjusted and adjusted for age, smok-
ing, alcohol intake, education, physical activity, and meno-
pause hormone therapy, were calculated using logistic
regression. Due to a wide span between the lowest and
the highest value of polyphenol intake, OR for DPI was
calculated by 100 units (100mg/d). All tests of statistical
significance were two-sided. The SAS software version
9.2 (SAS Institute Inc., Cary, NC) was used for all the sta-
tistical calculations.
3. Results
Table 2 displays the mean dietary intakes in the studied post-
menopausal women, stratified by the CVD status. It was
found that CVD women had statistically lower energy input
as well as essential nutrient intakes (protein, carbohydrates,
total fat, saturated fat, and cholesterol) compared to the
women without CVD. Energy from food was lower in CVD
women approximately by 8%, protein by 6%, carbohydrate
by 7%, total fat and saturated fat by 11%, and cholesterol by
11.5%. Table 2 also provides the consumption of the most
important groups of food products that contain polyphenols,
which are vegetables, fruit, tea, and coffee [11]. There were no
significant differences in the intake of vegetables, fruits, and
tea between the groups of women. However, it was found that
women with CVD consumed significantly less coffee. DPI
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and DTAC, standardized for 1000 kcal of energy, were not
significantly different.
Taking into account the raw data, the variables tested
in this study, such as DPI and DTAC, were associated
with reduced odds of CVD in postmenopausal women
(Table 3). Analysis of this data indicates that the women
with higher DPI (per 100 units = 100mg/d) and higher
DTAC had 2.3% reduced odds of CVD. Adjustments for
multiple variables such as age, smoking, alcohol intake,
education, physical activity, and menopause hormone ther-
apy, however, reduced the odds ratio of CVD to 1.1% in
the case of DPI, while DTAC was no longer associated
with the reduced odds of CVD.
Table 4 shows the percentages of the women with CVD
in the individual quartiles of DTAC and DPI, unadjusted as
well as adjusted for age, smoking, alcohol intake, education,
physical activity, and menopause hormone therapy. The
mean values for the lowest versus highest quartiles were as
follows: for DPI, it was 948mg/d versus 2975.8mg/d and
for DTAC, it was 5.05mmol/d versus 19.87mmol/l. In the
case of both DPI and DTAC, the increasing percent of
CVD women within the decreasing DPI and DTAC quartiles
was observed. Given the unadjusted data, the least propor-
tion of the women with CVD (29.54%) was observed in the
highest quartile of DPI (14.28–191.82mmol/d) and the
largest proportion of the women with CVD (42.06%) was
in the lowest quartile of DTAC (range 0.22–7.18mmol/d).
In the case of unadjusted data concerning DPI, the largest
percentage of the women with CVD (42.84%) was found in
the lowest quartile of DPI (range 1120–1263mg/d) and the
least proportion of the women with CVD (28.15%) was
found in the highest quartile of DPI (2303–8793mg/d). Also
in this case, a significant decreasing trend toward the lower
percentage of CVD women within the individual increasing
DPI quartiles was observed, which was still significant even
after the adjustment for age, smoking, alcohol intake, educa-
tion, physical activity, and menopause hormone therapy. The
percentage of CVD women within the individual DTAC
quartiles was gradually decreasing. This trend was statisti-
cally significant. However, in a multiple-adjustment model,
this tendency was no longer significant for DTAC.
Table 5 shows the contributions of individual food cate-
gories to the DPI value in the women with and without
CVD. The total DPIs in the individual groups were
1766.39mg/d in the CVD women and 1920.57mg/d in the
women without CVD. These values were statistically signifi-
cant at p < 0 0001. The total DPIs in both study groups were
mostly affected by the consumption of beverages, which con-
tributed to the total DPI in 41.81% in the case of the CVD
women and in 44.19% in the women without CVD. These
differences were statistically significant at p < 0 001. In the
both groups of women, the coffee and tea consumption
accounted for about 98% of the beverages’ DPI value. The
remaining food categories contributed less to the total DPI
value. They were listed according to the decreasing impact:
fruits (26.31% in the CVD women and 24.05% in the women
without CVD), cereals (14.10% and 13.34%, resp.), vegetables
(12.12% and 11.88%, resp.), and other food categories (5.66%
and 6.54%, resp.). DPI values from vegetables (p = 0 044) and
other foods (p = 0 0002) were significantly lower in the
women diagnosed with CVD. Taking into account the
individual food products, given in a descending order, con-
sumption of tea (21.34%), coffee (19.56%), apples (12.79%),
potato (5.51%), and mixed bread (4.87%) had the largest
impact on DPI in CVD women, as measured by the
Table 2: Mean dietary intakes in the postmenopausal women by prevalence of CVD.
Consumption
Women diagnosed with CVD
N = 916
Women without CVD
N = 1683
Mean± SD Mean± SD p
Energy from food (kcal/d), mean, SD 1516.9± 579.5 1652.9± 628.1 <0.0001
Protein (g/d), mean, SD 55.6± 22.7 58.9± 23.6 <0.0001
Carbohydrate (g/d), mean, SD 209.1± 86.2 224.3± 90.1 <0.0001
Total fat (g/d), mean, SD 57.7± 28.7 64.9± 31.9 <0.0001
Saturated fat (g/d), mean, SD 21.7± 11.9 24.4± 13.0 <0.0001
Cholesterol (mg/d), mean, SD 207.1± 140.0 234.2± 153.7 <0.0001
Vegetables (g/d) 215.0± 156.0 214.0± 155.0 0.850
Fruits (g/d) 214.0± 226.0 216.0± 227.0 0.989
Tea (g/d) 360.9± 251.7 348.1± 250.6 0.180
Coffee (g/d) 129.6± 165.5 175.3± 171.9 <0.0001
DPI (mg/d/1000 kcal) 1243.0± 654.0 1236.0± 528.0 0.493
DTAC (mmol/d/1000 kcal) 7.7± 5.6 7.7± 4.6 0.099
Table 3: Odds ratios (ORs) and 95% confidence intervals (CIs) for
prevalence of CVD by dietary total antioxidant capacity
(continuous) and dietary polyphenol intake (per 100mg/d).
Variables
Model 1a
OR (95% CI)
Model 2b
OR (95% CI)
DPI (mg/d) 0.977 (0.968; 0.987) 0.989 (0.978; 0.999)
DTAC (mmol/d) 0.977 (0.964; 0.990) 0.992 (0.979; 1.005)
aUnadjusted. bAdjusted for age, smoking, alcohol intake, education, physical
activity, and menopause hormone therapy.
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percentage of the DPI value. Similarly, among women with-
out CVD, the most important foods that influenced DPI were
also (in a descending order) coffee (24.34%), tea (18.94%),
apples (12.33%), mixed bread (5.59%), and potato (5.56%).
The total and the partial (for each food category) DTAC
values forCVDwomenand thewomenwithoutCVDaregiven
in Table 6. The total DTAC of 10.84mmol/d in the women
diagnosed with CVD was significantly lower in comparison
to thatof11.85mmol/d in thewomenwithoutCVD.Beverages
were themain food categorywhich contributed inmore than a
half to theDTACtotal value: 53.87%and57.13% in thewomen
diagnosedwithCVDand in thewomenwithout CVD, respec-
tively. These differences were statistically significant at
p < 0 001. Among the beverages, which included alcoholic
and nonalcoholic drinks, the consumption of coffee and tea
affected the DTAC in the respective groups of women (with
Table 4: Percentages of CVD women, odds ratios (ORs), and 95% confidence intervals (CIs) for prevalence of CVD by quartiles of
DTAC and DPI.
Parameters Quartile 1 Quartile 2 Quartile 3 Quartile 4 p
DPI (mg/d)
Mean± SD 948.2± 236 1523.2± 142 2016.3± 154 2975.8± 724
Range (1120–1263) (1264–1759) (1760–2302) (2303–8793)
% CVDa 42.84 36.00 34.00 28.15 <0.0001
% CVDb 40.60 35.04 34.50 31.80 0.011
DTAC (mmol/d)
Mean± SD 5.05± 1.50 8.84± 0.96 12.20± 1.05 19.87± 9.74
Range (0.22–7.18) (7.19–10.48) (10.49–14.27) (14.28–191.82)
% CVDa 42.06 36.31 33.08 29.54 <0.0001
% CVDb 39.72 34.87 34.12 33.17 0.073
aUnadjusted. bAdjusted for age, smoking, alcohol intake, education, physical activity, and menopause hormone therapy.
Table 5: Contributions of food categories to DPI in the women with and without CVD.
Food categories
Women with CVD
N = 916
Women without CVD
N = 1683 p value
Beverages
mg/d (mean± SD) 738.47± 471 848.61± 492
<0.001
Contribution to
DTAC (%)
41.81 44.19
Major sources
(% contribution)∗
Tea (21.34), coffee (19.56) Coffee (24.34), tea (18.94)
Cereals
mg/d (mean± SD) 249.01± 150 256.17± 157
0.188
Contribution to
DTAC (%)
14.10 13.34
Major sources
(% contribution)∗
Mixed bread (4.87), rye bread (3.36), wheat
bread (3.20)
Mixed bread (5.59), pastry (2.83), rye bread
(2.91)
Fruit
mg/d (mean± SD) 464.72± 519 461.86± 499
0.735
Contribution to
DTAC (%)
26.31 24.05
Major sources
(% contribution)∗
Apples (12.79), plums (3.61), strawberries
(2.25)
Apples (12.33), plums (2.75), strawberries
(2.12)
Vegetables
mg/d (mean± SD) 214.09± 147 228.23± 156
0.044
Contribution to
DTAC (%)
12.12 11.88
Major sources (%
contribution)∗
Potato (5.51), tomato (1.49), cabbage (1.39) Potato (5.56), cabbage (1.33), tomato (1.30)
Other food
categories
mg/d (mean± SD) 100.10± 199 125.70± 208
0.0002
Contribution to
DTAC (%)
5.66 6.54
Major sources
(% contribution)∗
Cookies and pastry (2.50), cocoa products
(2.08), nuts and seeds (0.81)
Cookies and pastry (2.83), cocoa products
(2.53), nuts and seeds (0.86)
Total
mg/d (mean± SD) 1766.39± 865 1920.57± 825
<0.0001Contribution to
DTAC (%)
100 100
∗In each food category, individual food products with the strongest impact on the DPI were only listed.
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CVDandwithoutCVD) in the sameextentof97.8%.Theother
food categories ranked in terms of impact on theDTAC in the
womenwithCVDversus thewomenwithoutCVDwere fruits,
vegetables, other food categories, and cereals. DTAC from the
foods grouped in the category of other foods was significantly
lower in the CVD women (p < 0 0001). It was found that
withineachof thecategories of food, similar foodsaffectedpar-
tial DTACs in the both groups ofwomen. For example, apples,
strawberries, plums, andgrapesdeliveredmostof theDTACin
the fruit food category both in thewomenwithCVDand in the
women without CVD. Similar observations were made for
cereals, vegetables, and other food categories. With regard to
individual food products, a consumption of coffee (26.57%),
tea (26.11%), apples (5.81%), potato (5.63%), strawberries
(3.69%), and nuts and seeds (3.41%) had the greatest impact
on the DTAC in CVD women. Among the women without
CVD, the food products, which in the largest percentage
influenced on DTAC, were coffee (32.83%), tea (23.04%),
potato (5.65%), apples (5.57%), strawberries (3.38%), andnuts
and seeds (2.87%).
4. Discussion
The results of the present study indicated that polyphenol
intake and the antioxidant activity in postmenopausal CVD
women were significantly lower and accounted for
1766.39mg/d and 10.84mmol/d, respectively, versus
1920.57mg/d and 11.85mmol/d in the women without
CVD. However, lower energy intake among women with
CVD compared to the women without history of CVD led
us to make adjustments for energy. After the adjustment to
1000 kcal, both DPI and DTAC did not differ between the
groups. Interestingly, in contrast to the current research, in
an earlier analysis based on the WOBASZ (2003–2005) study
Table 6: Contributions of food categories to DTAC in the women with and without CVD and major dietary sources that impact DTAC
within each food category.
Food categories
Women with CVD
N = 916
Women without CVD
N = 1683 p value
Beverages
mmol/d
(mean± SD) 5.84± 3.84 6.77± 4.03 <0.001
Contribution to
DTAC (%)
53.87 57.13
Major sources
(% contribution)∗
Coffee (26.57), tea (26.11) Coffee (32.83), tea (23.04)
Cereals
mmol/d (mean
± SD) 0.38± 0.29 0.39± 0.27
0.206
Contribution to
DTAC (%)
3.51 3.29
Major sources
(% contribution)∗
Mixed bread (1.11), rye bread (0.83), wheat
bread (0.74)
Mixed bread (1.27), rye bread (0.68), wheat
bread (0.59)
Fruit
mmol/d (mean
± SD) 2.19± 3.48 2.11± 3.05
0.427
Contribution to
DTAC (%)
20.20 17.81
Major sources
(% contribution)∗
Apples (5.81), strawberries (3.69), plums (2.03),
grapes (1.94)
Apples (5.57), strawberries (3.38), plums (1.6),
grapes (1.43)
Vegetables
mmol/d (mean
± SD) 1.67± 1.58 1.77± 1.62
0.124
Contribution to
DTAC (%)
15.41 14.94
Major sources
(% contribution)∗
Potato (5.63), beetroot (2.77), cabbage (1.85),
tomato (1.11), broccoli and cauliflower (0.92)
Potato (5.65), beetroot (2.70), cabbage (1.94),
broccoli and cauliflower (1.01), tomato (0.93)
Other
foods
mmol/d (mean
± SD) 0.76± 5.82 0.81± 3.46
<0.0001Contribution to
DTAC (%)
7.01 6.83
Major sources
(% contribution)∗
Nuts and seeds (3.41), cocoa products (1.85),
cookies and pastry (0.73)
Nuts and seeds (2.87), cookies and pastry
(2.87), cocoa products (1.94)
Total
mmol/d (mean
± SD) 10.84± 8.53 11.85± 6.66 <0.0001
Contribution to
DTAC (%)
100 100
∗In each category of food products, only those that had the greatest impact on the DTAC were listed.
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concerning CVD women of different ages, an increase in die-
tary antioxidant activity and a greater consumption of poly-
phenols than those in the healthy women were observed,
which was explained by healthier dietary choices by CVD
women [21]. In contrast, the present study shows dietary
modifications made by postmenopausal CVD women in
terms of reduced calorie and coffee intakes, but the consump-
tion of vegetables and fruits was at a similar level. These mod-
ifications were reflected in the DPI and DTAC values. At the
same time, the study indicates (after the adjustment of model
for multiple variables as age, smoking, alcohol intake, educa-
tion, physical activity, and menopause hormone therapy)
that there was a small reduction observed with regard to
DPI, but no decline in the odds of CVD in the women
according to DTAC. In addition, it was found that coffee
and tea were the main sources of DPI and DTAC in the stud-
ied postmenopausal women, which is consistent with other
observations in Polish urban population [22].
Senescence is characterized by increased rates of hyper-
tension, diabetes, CVD, and cancer [23]. Several studies
found an inverse relationship between dietary total antioxi-
dant capacity (DTAC) and the risk of chronic diseases in
aging people. A meta-analysis of those data concluded that
DTAC has a great potential for clinical applications and pub-
lic health [24]. Previously, we found a diminished DTAC
value in an elderly population, and particularly in the elderly
women, compared to that in the young and middle-aged sub-
jects [25]. DTAC, among other things, corresponds with
polyphenol content in the diet. It has not been established,
however, whether the effect of polyphenols on cardiovascular
health is directly related to their antioxidant activity [26].
Several other mechanisms of polyphenol action in humans,
which are not related to direct antioxidant activity, have been
suggested, including microbiota transformation or the
enhancement of internal mechanisms of antioxidant protec-
tion [27, 28]. Regardless of the mechanisms of action, benefi-
cial polyphenol effects on the heart health were observed. In
the PREDIMED study, a 46% reduction in the risk of CVD
during 4.3 years of a follow-up period was observed, compar-
ing Q5 with Q1 of total polyphenol intake [29]. Recently, we
found that the existing databases of dietary polyphenols are
partially incomplete and should be further expanded to bet-
ter reflect the dietary polyphenol contents in foods [11].
Therefore, on the basis of our own dietary database [17, 18]
as well as of other available published databases [20] and tak-
ing into account the amounts of individual food consumed,
we calculated dietary polyphenol intakes (DPI) for postmen-
opausal women with CVD and the non-CVD women.
Likewise, dietary total antioxidant capacity (DTAC) was
calculated using our own [17, 18] and other commonly acces-
sible databases [19], which are based on the FRAP (ferric-
reducing antioxidant potential) assay. At this point, it should
be mentioned that the research methodology of dietary TAC
is varied. The FRAP assay is the most widely used experimen-
tal method to assess TAC in foods, although several methods
have been developed for measuring total antioxidant capacity
[27]. Several studies demonstrate that higher TAC from diet
and supplements beneficially alters lipid and glucose profiles
[30, 31], improves endothelial function [32], and reduces
systemic inflammation [33]. Recent clinical studies have
shown that higher TAC from diet and supplements can be
associated with a decrease in inflammatory markers in over-
weight/obese postmenopausal women [34]. Supplements in
this study largely contributed to the TAC value. Conversely,
reduced rates of CVD were not observed for a single antiox-
idant vitamin supplement (beta-carotene, vitamin C, and
vitamin E) users in randomized controlled trials [35, 36]. In
contrast to this research, supplementation in our study was
not calculated, with reference to the purpose of the study,
which was to demonstrate a dietary impact on TAC. In addi-
tion to this, in various studies, DTAC has been calculated
with different methods. DTAC in our own study was deter-
mined by using the experimental FRAP method that mea-
sures combined TACs of food samples [27]. It is common
to use the FRAP assay in order to assess the relationship
between the dietary TAC and the occurrence of diseases. In
several studies, a negative association between the dietary
TAC and the occurrence of cancers has been found [37,
38], although not all studies support the existence of such
dependency [39]. Another approach is to determine DTAC
on the basis of theoretical calculations of individual antioxi-
dants (polyphenols, carotenoids, and vitamins C and E) in
food products. In our study, however, TAC value of individ-
ual food products results from a complex interaction of many
of the components included in one food sample. We found,
however, that diets with higher TAC, after adjustment for
potential confounders for CVD in postmenopausal women
such as age, smoking, alcohol intake, education, physical
activity, and menopause hormone therapy, in contrast to
DPI, were not associated with the reduced odds of CVD. Pos-
sibly, the content of antioxidants in the diet is insufficient to
significantly affect the level of antioxidants in the human
body. Generally, despite polyphenol dietary abundance, their
bioavailability is rather low [26]. Therefore, other mecha-
nisms for their actions are suggested, as it was mentioned
before. In addition, bioavailability of some other food ingre-
dients, such as carotenoids, for example, can be negatively
affected by the digestion and absorption process [40].
Quartile analysis provides more information on the
relationship between DTAC and DPI and the prevalence
of CVD. Despite that DTAC in the upper quartile is
almost four times higher than that in the bottom quartile,
the number of women with CVD in the upper quartile is
only about 17% lower in the model of multiple adjust-
ments than that in the bottom quartile, and this trend is
not significant. A similar situation applies to DPI, which
in the upper quartile is three times higher than that in
the lower quartile, while the number of women with
CVD in the upper quartile is only ~22% lower than that
in the bottom quartile. However, in the case of DPI, this
trend is statistically significant, showing that the total
polyphenol intake may affect the incidence of CVD only
to a small extent, while other factors such as lifestyle-
related factors, may be relevant to CVD risk in postmeno-
pausal women. It is also possible that only an in-depth
analysis of individual polyphenols could give the answer
to the argument raised in this paper, but this requires fur-
ther analysis.
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By comparing the composition of the diets in the both
groups of women, we found that the supply of energy, pro-
tein, carbohydrates, and fats was significantly lower in the
women with CVD. Lower energy and nutrient intakes might
have resulted somewhat from both an older age of the CVD
women and possibly due to the nutritional restrictions
because of the increased body mass as well as larger preva-
lence of diabetes in the group of CVD women. CVD women
in this study were characterized by a higher proportion of
obesity cases [44.3%) and diabetes (19.8%) compared to
non-CVD women (32.2% and 13.4%, resp.). The prevalence
of overweight and obesity is common in postmenopausal
women in the Polish population [41], and an excessive body
weight is associated with oxidative stress [42]. We also found
that despite the lower energy and nutrient intakes from the
diet, the supply of vegetables and fruits in the postmeno-
pausal CVD women remained similar to that in the women
without CVD. Vegetables and fruit are together a group of
food that was consumed in the highest amounts (together,
they represent the amount of 430 g/d). They were one of
the main sources of antioxidants and polyphenols in the both
groups of women. Also, the structure of food consumed by
the participants was similar in the respective groups of
women. The main beverages in either case were coffee and
tea. The tea intake did not differ significantly between the
two groups of women, while the consumption of coffee was
significantly lower among CVD women. Some alcoholic bev-
erages, such as wine and beer, which normally are polyphe-
nolic supplies for the general population, had no impact on
the DPI and DTAC values in the studied group of postmen-
opausal women.
The results concerning the intake of coffee and the risk of
CVD are conflicting. One of the most important risk factors
of CVD is high blood pressure. In hypertensive elderly pop-
ulations, a habitual coffee drinking may lead to uncontrolled
blood pressure (BP) [43]. However, several cohort studies
and a meta-analysis do not confirm an association between
longer-term coffee consumption and increased BP and also
between habitual coffee consumption and the increased risk
of CVD in hypertensive subjects [44]. In other study in
Poland, it was indicated that the risk of hypertension was
lower in persons consuming moderate amount of coffee (3-
4 cups/day) and higher intake of coffee was not protective
[45]. A literature search shows that moderate intake of coffee
appears to be protective against CVD [46–49] and coffee con-
sumption can confer benefits, particularly for postmeno-
pausal women, by reducing inflammation and the risk of
CVD [50]. Recent studies demonstrate that drinking 1-2 cups
of coffee per day in women reduces the risk of mortality due
to CVD, and this effect was observed in nonsmokers only
[46]. Interestingly, DPI and DTAC from the remaining food
categories did not differ in principle, with the exception of
the category of other foods (for DPI and DTAC) and
vegetables (for DPI). But overall, the beverages had a
determining influence on the total values of the DPI and
DTAC. In addition, the analysis of the structure of the
DTAC and DPI in various food categories indicates simi-
lar selection of food products in the both groups of
women (with CVD and without CVD).
This study has its strengths and limitations. The advan-
tage of this population-based study is a large group of post-
menopausal women; however, the participation rate in the
WOBASZ II study was rather low. Also, this study provides
data regarding the relationship between DTAC and the prev-
alence of CVD in postmenopausal women, which was not so
far studied. Among the limitations, first is the cross-sectional
nature of the study which does not allow to present time
sequence between the disease and exposure. The results
may be biased by the reverse causality; persons after the diag-
nosis of CVD could have been advised to change the diet and
to decrease the consumption of coffee. Next, a single 24-hour
recall does not reflect the long-term consumption. Therefore,
small dietary variations of the examined women might have
affected the results obtained. However, there is no satisfac-
tory tool to evaluate food consumption, and each of these
methods has its strengths and weaknesses [51]. The single
24-hour recall method was used in WOBASZ and WOBASZ
II studies, because in contrast to other methods, it is simple,
inexpensive, and relatively brief, with less potential to inter-
fere with respondent’s dietary behavior and usually with a
better response rate which translates into increased represen-
tativeness of the population. For these reasons, it is often used
in epidemiological studies. Possibly, the use of multiday
recalls would be more beneficial, because they give better esti-
mates of the population’s dietary intake [51], but there is
more burden on the respondents. Another alternative for
the 24-hour recall is a food frequency questionnaire. This lat-
ter, however, does not measure many details of dietary
intake, which is essential for the good interpretation of die-
tary intake of polyphenols, which are present in a variety of
foods. For the above reasons, a single 24-hour recall method
was selected.
5. Conclusion
In this study, higher dietary polyphenol intake, but not the
dietary total antioxidant capacity, was found to be inversely
associated with CVD in postmenopausal women, which
points to the health benefits of increased polyphenol intake
from food sources for these women.
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